At present, GP73 has attracted more and more attention as a serological marker for liver cancer.178 Most of the studies suggest that GP73 can improve the diagnostic rate for liver cancer (Table 1), and its sensitivity and specificity are higher than that of AFP, a traditional hepatoma serum marker. This evidence concerns the gene AFP and hepatocellular carcinoma.